USA. Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels  The Department of Health and Human Services (“HHS” or “Department”) herein publishes the panels of Schedule I and II drugs and biomarkers author...

USA. DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients “DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the div...

USA. Federal Guidelines for Opioid Treatment Programs (2024)  This manual provides guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administrati...

A scoping review and consensus recommendations for emergency medical services buprenorphine (EMS-Bupe) programs.  Joiner AP, Wanthal J, Murrell AN, Cabañas JG, Carroll G, Hern G, Sasser M, Poland C, Mercer M, Glenn M.  Prehosp Emerg Ca...

SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk  This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these te...

Neue Leitlinien stellen fortschrittliche Strategien zur HIV-Behandlung und -Prävention vor Gremium der International Antiviral Society-USA (IAS-USA) veröffentlicht Empfehlungen für 2024 (dzif – deutsches zentrum für infektionsforschung, 12.12.20...